JPET Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by GRAEFF, F. G.
Right arrow Articles by SCHOENFELD, R. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GRAEFF, F. G.
Right arrow Articles by SCHOENFELD, R. I.
Journal of Pharmacology And Experimental Therapeutics, Vol. 173, Issue 2, 277-283, 1970
Copyright © 1970 by American Society for Pharmacology and Experimental Therapeutics


TRYPTAMINERGIC MECHANISMS IN PUNISHED AND NONPUNISHED BEHAVIOR

F. G. GRAEFF 1 and R. I. SCHOENFELD 1

1 Department of Pharmacology, Harvard Medical School, Boston, Massachusetts

The dose-effect relationships of two tryptaminic antagonists, methysergide and bromolysergic acid, and the agonist, agr-methyltryptamine, on key-pecking behavior of the pigeon were determined. A multiple fixed-interval five-minute fixed-ratio 30-response food presentation schedule and a concurrent fixed-interval five-minute food, fixed-ratio 30-electric-shock punishment schedule were used. Lower doses of the two tryptaminic antagonists increased low response rates occurring at the beginning of the fixed-interval component of the multiple schedule and the overall response rates of the punished fixed interval. They also increased the high overall rates of responding during the fixed ratio. Higher doses of methysergide and bromolysergic acid decreased high rates of responding occurring at the end of the fixed-interval and the fixed-ratio components of the multiple schedule. agr-Methyltryptamine produced only decreases in responding with both schedules studied. These results suggest the existence of a tryptaminergic mechanism involved in behavioral inhibition.

Submitted on October 24, 1969
Accepted on February 19, 1970




This article has been cited by other articles:


Home page
J PsychopharmacolHome page
A. Rex, H. Fink, M. Skingle, and C.A. Marsden
Involvement of 5 -HT1D receptors in cortical extracellular 5-HT release in guinea-pigs on exposure to the elevated plus maze
J Psychopharmacol, January 1, 1996; 10(3): 219 - 224.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
A. Rex, C.A. Marsden, and H. Fink
5-HT 1A receptors and changes in extracellular 5-HT in the guinea-pig prefrontal cortex: involvement in aversive behaviour
J Psychopharmacol, January 1, 1993; 7(4): 338 - 345.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
J.E. Barrett, S. Gleeson, M.A. Nader, and S.M. Hoffmann
Anticonflict effects of the 5-HT1A compound flesinoxan
J Psychopharmacol, January 1, 1989; 3(2): 64 - 69.
[Abstract] [PDF]


Home page
ScienceHome page
R. Schoenfeld
Lysergic acid diethylamide- and mescaline-induced attenuation of the effect of punishment in the rat
Science, May 21, 1976; 192(4241): 801 - 803.
[Abstract] [PDF]


Home page
ScienceHome page
C. D. Wise, B. D. Berger, and L. Stein
Benzodiazepines: Anxiety-Reducing Activity by Reduction of Serotonin Turnover in the Brain
Science, July 14, 1972; 177(4044): 180 - 183.
[Abstract] [PDF]


Home page
ScienceHome page
R. I. Schoenfeld
Melatonin: Effect on Punished and Nonpunished Operant Behavior of the Pigeon
Science, March 26, 1971; 171(3977): 1258 - 1260.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1970 by the American Society for Pharmacology and Experimental Therapeutics.